Vimarsana
Biggest News Aggregation in the World

Page 12 - Major Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Major Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Major Project Today - Breaking & Trending Today

Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting - Vimarsana News

Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Wellington Gateway offers faster transit to bustling street - Vimarsana News

Wellington Gateway offers faster transit to bustling street

Wellington Street is getting a massive upgrade as part of the new rapid transit plan in London. The "Wellingto...

Six Healthy Lifestyle Habits Linked to Slowed Memory Decline - Vimarsana News

Six Healthy Lifestyle Habits Linked to Slowed Memory Decline

This study found that six healthy lifestyle factors slowed memory decline in older adults over a 10-year period, regardless of whether they were APOE4 carriers.

China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List - Vimarsana News

China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference - Vimarsana News

Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...